KYTHERA BIOPHARMACEUTICALS INC - FORM 10-K - EX-23.1 - March 2, 2015

Attached files

file filename
EX-31.1 - EX-31.1 - KYTHERA BIOPHARMACEUTICALS INCa2223273zex-31_1.htm
EX-32.1 - EX-32.1 - KYTHERA BIOPHARMACEUTICALS INCa2223273zex-32_1.htm
EX-21.1 - EX-21.1 - KYTHERA BIOPHARMACEUTICALS INCa2223273zex-21_1.htm
EX-10.21 - EX-10.21 - KYTHERA BIOPHARMACEUTICALS INCa2223273zex-10_21.htm
EX-10.20 - EX-10.20 - KYTHERA BIOPHARMACEUTICALS INCa2223273zex-10_20.htm
EX-10.8(C) - EX-10.8(C) - KYTHERA BIOPHARMACEUTICALS INCa2223273zex-10_8c.htm
EX-10.22 - EX-10.22 - KYTHERA BIOPHARMACEUTICALS INCa2223273zex-10_22.htm
EXCEL - IDEA: XBRL DOCUMENT - KYTHERA BIOPHARMACEUTICALS INCFinancial_Report.xls
10-K - 10-K - KYTHERA BIOPHARMACEUTICALS INCa2223273z10-k.htm
EX-31.2 - EX-31.2 - KYTHERA BIOPHARMACEUTICALS INCa2223273zex-31_2.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

        We consent to the incorporation by reference in the following Registration Statements:

    •
    Registration Statement (Form S-8 No. 333-184439) pertaining to the KYTHERA Biopharmaceuticals, Inc. 2004 Stock Plan, as amended, and the KYTHERA Biopharmaceuticals, Inc. 2012 Equity Incentive Award Plan;

    •
    Registration Statements (Form S-8 Nos. 333-187538 and 333-194735) pertaining to the KYTHERA Biopharmaceuticals, Inc. 2012 Equity Incentive Award Plan;

    •
    Registration Statement (Form S-8 No. 333-198512) pertaining to the KYTHERA Biopharmaceuticals, Inc. 2014 Employment Commencement Incentive Plan;

    •
    Registration Statement (Form S-8 No. 333-202104) pertaining to the KYTHERA Biopharmaceuticals, Inc. 2012 Equity Incentive Award Plan and the KYTHERA Biopharmaceuticals, Inc. 2015 Employee Stock Purchase Plan; and

    •
    Registration Statements (Form S-3 No. 333-198511 and Amendment No. 1 thereto) relating to Common Stock; Preferred Stock; Debt Securities; Warrants; Purchase Contracts; and Units of KYTHERA Biopharmaceuticals, Inc. and in the related Prospectus;

of our report dated March 2, 2015, with respect to the consolidated financial statements of KYTHERA Biopharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2014.

    /s/ Ernst & Young LLP

Los Angeles, California
March 2, 2015



QuickLinks

Consent of Independent Registered Public Accounting Firm

KYTHERA BIOPHARMACEUTICALS INC Reports

Also read